What question did this study set out to answer?

To examine whether insulin functions as an endogenous cardioprotector and evaluate the importance of maintaining euglycemia during acute myocardial infarction.

January 1, 2002Critical CareOpen Access

Is insulin an endogenous cardioprotector?

View Full Paper

Ask AI

Bookmark

Why the study?

Does maintaining euglycemia with a glucose-insulin-potassium cocktail improve cardiac function and reduce infarct size in patients with acute myocardial infarction?

Key Points

To examine whether insulin functions as an endogenous cardioprotector and evaluate the importance of maintaining euglycemia during acute myocardial infarction.
Narrative synthesis of physiological mechanisms linking stress hyperglycemia, inflammatory pathways, and cardiovascular outcomes in acute myocardial infarction and critical illness.
Evaluation of metabolic interventions, including glucose-insulin-potassium regimens targeting plasma glucose levels ≤ 110 mg/dl.
Hyperglycemia triggers free radical generation and inhibits endothelial nitric oxide production, driving inflammation and increasing the risk of in-hospital death, heart failure, and cardiogenic shock.
Insulin directly counters these toxic effects by suppressing tumor necrosis factor-alpha and free radical production while enhancing endothelial nitric oxide generation and myocardial function.

Structured PICO

Does maintaining euglycemia with a glucose-insulin-potassium cocktail improve cardiac function and reduce infarct size in patients with acute myocardial infarction?

Population

Patients with acute myocardial infarction and critically ill patients

Intervention

Glucose-insulin-potassium cocktail to maintain euglycemia (plasma glucose <= 110 mg/dl)

Maintaining euglycemia with a glucose-insulin-potassium cocktail is proposed as a strategy to reduce infarct size and improve cardiac function in acute myocardial infarction.

Authors

UDUndurti N. DasWolf Park

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Hypothesis-generating for GIK in acute MI; leaves open efficacy pending randomized trials.

Cite This Study

Undurti N. Das (2002) studied this question.

synapsesocial.com/papers/6a7ef12c084666b5350d32fb https://doi.org/10.1186/cc1535

View Full Paper

Ask AI

Bookmark

Is insulin an endogenous cardioprotector?

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Is insulin an endogenous cardioprotector?

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider